Abstract: Embodiments according to the present disclosure are directed to, for example, head mounted eyewear (e.g., similar in form to traditional eye glasses) that includes low light vision enhancing and/or additional vision enhancing capabilities (e.g., near-vision enhancing capabilities). For example, in some embodiments, a head mounted housing arrangement is provided that includes an eyepiece adjacent to a wearer's eye, one or more imaging devices (e.g., one or more solid state or other imagers sensitive to light, including low light levels), one or more image generator(s) operatively coupled to the imager(s) (e.g., optically coupled, in electrical communication with, or wirelessly coupled) to receive an output from the imaging device(s), and/or one or more optical elements (e.g., a combination of mirror(s) and/or lenses). The one or more optical elements may place an output of the image generator(s) into a position that is visible to the wearer's eye.

Abstract: Embodiments according to the present disclosure are directed to, for example, head mounted eyewear (e.g., similar in form to traditional eye glasses) that includes low light vision enhancing and/or additional vision enhancing capabilities (e.g., near-vision enhancing capabilities). For example, in some embodiments, a head mounted housing arrangement is provided that includes an eyepiece adjacent to a wearer's eye, one or more imaging devices (e.g., one or more solid state or other imagers sensitive to light, including low light levels), one or more image generator(s) operatively coupled to the imager(s) (e.g., optically coupled, in electrical communication with, or wirelessly coupled) to receive an output from the imaging device(s), and/or one or more optical elements (e.g., a combination of mirror(s) and/or lenses). The one or more optical elements may place an output of the image generator(s) into a position that is visible to the wearer's eye.

Abstract: Embodiments according to the present disclosure are directed to, for example, head mounted eyewear (e.g., similar in form to traditional eye glasses) that includes low light vision enhancing and/or additional vision enhancing capabilities (e.g., near-vision enhancing capabilities). For example, in some embodiments, a head mounted housing arrangement is provided that includes an eyepiece adjacent to a wearer's eye, one or more imaging devices (e.g., one or more solid state or other imagers sensitive to light, including low light levels), one or more image generator(s) operatively coupled to the imager(s) (e.g., optically coupled, in electrical communication with, or wirelessly coupled) to receive an output from the imaging device(s), and/or one or more optical elements (e.g., a combination of mirror(s) and/or lenses). The one or more optical elements may place an output of the image generator(s) into a position that is visible to the wearer's eye.

Abstract: Embodiments according to the present disclosure are directed to, for example, head mounted eyewear (e.g., similar in form to traditional eye glasses) that includes low light vision enhancing and/or additional vision enhancing capabilities (e.g., near-vision enhancing capabilities). For example, in some embodiments, a head mounted housing arrangement is provided that includes an eyepiece adjacent to a wearer's eye, one or more imaging devices (e.g., one or more solid state or other imagers sensitive to light, including low light levels), one or more image generator(s) operatively coupled to the imager(s) (e.g., optically coupled, in electrical communication with, or wirelessly coupled) to receive an output from the imaging device(s), and/or one or more optical elements (e.g., a combination of mirror(s) and/or lenses). The one or more optical elements may place an output of the image generator(s) into a position that is visible to the wearer's eye.

Abstract: Embodiments according to the present disclosure are directed to, for example, head mounted eyewear (e.g., similar in form to traditional eye glasses) that includes low light vision enhancing and/or additional vision enhancing capabilities (e.g., near-vision enhancing capabilities). For example, in some embodiments, a head mounted housing arrangement is provided that includes an eyepiece adjacent to a wearer's eye, one or more imaging devices (e.g., one or more solid state or other imagers sensitive to light, including low light levels), one or more image generator(s) operatively coupled to the imager(s) (e.g., optically coupled, in electrical communication with, or wirelessly coupled) to receive an output from the imaging device(s), and/or one or more optical elements (e.g., a combination of mirror(s) and/or lenses). The one or more optical elements may place an output of the image generator(s) into a position that is visible to the wearer's eye.

Abstract: The invention provides methods of treating or preventing a condition or disorder associated with dyslipidemia with compositions comprising apolipoprotein-sphingomyelin complexes. The methods of the invention permit reduction, by 4- to 20-fold, of the amount of apolipoprotein required for therapeutic administration to bring about an ameliorative effect.

Abstract: The invention provides methods of treating or preventing a condition or disorder associated with dyslipidemia with compositions comprising apolipoprotein-sphingomyelin complexes. The methods of the invention permit reduction, by 4- to 20-fold, of the amount of apolipoprotein required for therapeutic administration to bring about an ameliorative effect.

Abstract: The present invention relates to methods for high information content (HIC) analysis or screening of complex biological systems using Fourier transform mass spectrometry (FTMS). The present methods are useful for analyzing complex biological mixtures containing both high molecular weight molecules (e.g., polynucleotides, proteins, polysaccharides) and low molecular weight molecules (e.g., oligonucleotides, peptides, lipids, oligosaccharides, steroid hormones, catabolic and metabolic intermediates) permit the elucidation of molecular differences between complex biological samples, and permit the identification of biologically active molecules (e.g. therapeutically active drugs, etc.).

Abstract: The invention provides methods of treating or preventing a condition or disorder associated with dyslipidemia with compositions comprising apolipoprotein-sphingomyelin complexes. The methods of the invention permit reduction, by 4- to 20-fold, of the amount of apolipoprotein required for therapeutic administration to bring about an ameliorative effect.

Abstract: The present invention relates to methods for high information content (HIC) analysis or screening of complex biological systems using Fourier transform mass spectrometry (FTMS). The present methods are useful for analyzing complex biological mixtures containing both high molecular weight molecules (e.g., polynucleotides, proteins, polysaccharides) and low molecular weight molecules (e.g., oligonucleotides, peptides, lipids, oligosaccharides, steroid hormones, catabolic and metabolic intermediates) permit the elucidation of molecular differences between complex biological samples, and permit the identification of biologically active molecules (e.g. therapeutically active drugs, etc.).

Abstract: The present invention relates to methods for high information content (HIC) analysis or screening of complex biological systems using Fourier transform mass spectrometry (FTMS). The present methods are useful for analyzing complex biological mixtures containing both high molecular weight molecules (e.g., polynucleotides, proteins, polysaccharides) and low molecular weight molecules (e.g., oligonucleotides, peptides, lipids, oligosaccharides, steroid hormones, catabolic and metabolic intermediates) permit the elucidation of molecular differences between complex biological samples, and permit the identification of biologically active molecules (e.g. therapeutically active drugs, etc.).

Abstract: The present invention provides a recombinant DNA sequence encoding the pseudorabies virus (PRV) glycoprotein gX, host cells transformed by said DNA sequence, the gX polypeptide, and methods and kits for detecting animals infected with PRV.

Abstract: The present invention provides a recombinant DNA sequence encoding the pseudorabies virus (PRV) glycoprotein gX, host cells transformed by said DNA sequence, the gX polypeptide, and methods and kits for detecting animals infected with PRV.